15:57 Feb 25

Gland Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1848.50
+46.10 (+2.56%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Gland Pharma Ltd. Financials

Gland Pharma Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1848.50
+46.10 (+2.56%)
15:57 Feb 25
Quality
image/svg+xml

70/100
High Financial Strength

Valuation
image/svg+xml

35/100
Mid Valuation

Technical

45/100
Technically Neutral

Strength

10

Weakness

4

Opportunity

1

Threats

0

7.63 %

ROE %

6.22 %

ROA %

51.42

EPS

555.40

BVPS

12.43 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
3462.88 4400.71 3624.6 5664.72 5616.5
Operating Expenses +
2160.65 2890.55 2599.83 4331.65 4347.58
Raw Material
1765.36 2072.52 1732.34 2275.2 2186.12
Increase Decrease in Cost
-273.49 36.69 -46.92 127.88 103.41
Other Manufacturing Expense
74.58 95.05 124.84 0 0
Employee Cost
311.36 338.57 403.26 1256.89 1401.56
Miscellaneous Expenses
315.24 399.04 417.49 717.82 685.47
Operating Profit
1302.23 1510.16 1024.77 1333.07 1268.92
Other Income
134.78 223.94 240.46 170.24 213.61
Depreciation
98.78 110.3 146.74 344.57 377.87
Interest
3.41 5.24 7.45 26.2 42
Profit before tax and exceptio..
1334.81 1618.55 1111.04 1132.54 1062.66
Exceptional Items
0 0 -56.46 0 0
PBT
1334.81 1618.55 1054.58 1132.54 1062.66
Provision for Taxation
337.85 406.89 273.54 360.08 364.13
Net Profit
996.96 1211.66 781.04 772.46 698.53
NET Profit after MI
996.96 1211.66 781.04 772.46 698.53
EPS
62.99 73.81 47.43 46.9 42.4
Operating Profit Margin (%)
37.61 34.32 28.27 23.53 22.59
Net Profit Margin (%)
28.79 27.53 21.55 13.64 12.44

Gland Pharma Ltd. Shareholding

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 51.80 51.80 51.80 51.80 51.80 51.80
FII 7.60 7.90 7.40 6.90 5.00 4.50
Public 33.00 32.60 32.80 33.30 34.80 35.30
Others 7.60 7.70 8.00 8.00 8.40 8.40
Shareholder Shares Holding %
Download Our App On: